[TEVA] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
11-May-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -1,129.31%
YoY- -2,450.39%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 3,870,000 4,337,000 4,701,000 5,686,000 5,038,000 4,966,000 5,045,000 -4.31%
PBT -51,000 -850,000 -250,000 -5,978,000 256,000 621,000 847,000 -
Tax -104,000 -179,000 -76,000 -22,000 29,000 88,000 102,000 -
NP 140,000 -689,000 -176,000 -5,970,000 254,000 539,000 748,000 -24.34%
Tax Rate - - - - -11.33% -14.17% -12.04% -
Total Cost 3,730,000 5,026,000 4,877,000 11,656,000 4,784,000 4,427,000 4,297,000 -2.32%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 3.62 -15.89 -3.74 -104.99 5.04 10.85 14.83 -20.92%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 0.13 -0.63 -0.18 -5.88 0.28 0.64 0.88 -27.27%
EPS Diluted 0.13 -0.63 -0.17 -5.87 0.28 0.63 0.87 -27.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.